Major Corporate Updates and Q2 Earnings Report

Maruti Suzuki domestic wholesale volumes surged 37.8% YoY to 5.65 lakh units, while Jubilant Ingrevia reported revenue of Rs 1,394 Cr, up 24% YoY.

Reader Takeaway: Strong volume growth in auto and capacity additions in cement signal operational expansion amidst mixed Q2 earnings.

What just happened

Corporate activity across the BSE/NSE landscape intensified with major announcements today. Alembic Pharma received US FDA approval for its Valganciclovir Oral Solution, a drug used for CMV retinitis. In the infrastructure space, JSW Cement greenlit significant expansion, adding 2 MTPA grinding capacity at Vijayanagar and another 2 MTPA at Dolvi. Meanwhile, ACME Solar commissioned an additional 35.77 MW of BESS capacity, bringing its total to 195.35 MW/781.40 MWh.

Q2 Result Highlights

Jubilant Ingrevia showcased strong performance, with EBITDA rising 57% YoY to Rs 212 Cr, supported by management's reiteration of its FY27 EBITDA guidance. In the automotive sector, Bajaj Auto saw export volumes climb 41% YoY, and its subsidiary, BACL, reported a robust 85% YoY jump in PAT. Cipla’s US sales hit US$172 million, with margins expanding 200 bps QoQ to 18.7%.

Risks to watch

Shareholders should note a reported fire incident at a Gulf Oil warehouse in Gujarat. While the company confirmed no casualties, the financial impact remains under assessment. Additionally, investors should track whether Maruti Suzuki can sustain high volume growth against current margin pressures (8.9% EBITDA margin reported).

Context metrics

Exide Industries continues to strengthen its energy storage play, having invested a further Rs 150 Cr in its subsidiary, Exide Energy Solutions, taking cumulative investment to Rs 5,352 Cr. Lemon Tree Hotels has also signaled continued expansion by signing a new property in Punjab.